Monthly
US$200
Billed every month
Sign in to subscribeIguratimod Tablets
As of 13 November 2026, for Iguratimod Tablets, 23 applications are listed as under review at China's CDE; 13 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 25 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 3 applicationsAccepted: 2 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders25View records ↓
Under-review filings23View records ↓
This year’s generic filers13View records ↓
NHSA approval numbers22View records ↓
API companies with A status23View records ↓
Chemical-drug catalogue
Loaded records: 25 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 24 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20266052 | 2026/09/22 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Rui Qi Pharma Co., Ltd. romanized | Shandong Luo Xin Pharma Group Co., Ltd. romanized | 国药准字H20265780 | 2026/09/02 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Ai Li De Pharmaceutical Co., Ltd. romanized | Anhui Ai Li De Pharmaceutical Co., Ltd. romanized | 国药准字H20265702 | 2026/08/25 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | 国药准字H20265655 | 2026/08/18 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 2026/08/04 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jin Hong Pharma Co., Ltd. romanized | Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 2026/06/30 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Pioneer Pharmaceutical Co., Ltd | Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 2026/06/17 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20264700 | 2026/06/10 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 2026/06/03 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20264305 | 2026/05/12 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 2026/03/31 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Ke Lun Pharma Co., Ltd. romanized | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20263509 | 2026/03/03 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20263205 | 2026/01/27 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Changchun Hai Yue Pharma Co., Ltd. romanized | Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 2026/01/20 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20256507 | 2025/12/30 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20256365 | 2025/12/22 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 2025/12/09 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Shuo De Pharma Co., Ltd. romanized | Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20255709 | 2025/10/14 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Gowell Pharmaceutical Co., Ltd. | Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20254798 | 2025/07/08 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20253637 | 2025/03/18 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 2024/06/28 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Xian Sheng Pharma Co., Ltd. romanized | Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 2011/08/15 | 25mg | Innovative drug | CDE |
| Shandong Xian Dai Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20266105 | 2026/09/29 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Long Hai Pharma Co., Ltd. romanized | Hebei Long Hai Pharma Co., Ltd. romanized | 国药准字H20266143 | 2026/09/29 | 25mg | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 22 distinct approval numbers and 22 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010100177 | NHSA |
| Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 25mg | Category B | XM01AXA267A001010100591 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010101503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010101522 | NHSA |
| Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20253637 | 25mg | Category B | XM01AXA267A001010101749 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010103307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010104339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010104647 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20266052 | 25mg | Category B | XM01AXA267A001010104929 | NHSA |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20264305 | 25mg | Category B | XM01AXA267A001010104960 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010105001 | NHSA |
| Jiangxi Ke Lun Pharma Co., Ltd. romanized | 国药准字H20263509 | 25mg | Category B | XM01AXA267A001010105319 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20263205 | 25mg | Category B | XM01AXA267A001010105815 | NHSA |
| Hainan Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 25mg | Category B | XM01AXA267A001010105849 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20264700 | 25mg | Category B | XM01AXA267A001010105911 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010109568 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20256507 | 25mg | Category B | XM01AXA267A001010180685 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20254798 | 25mg | Category B | XM01AXA267A001010180937 | NHSA |
| Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20255709 | 25mg | Category B | XM01AXA267A001010183830 | NHSA |
| Anhui Rui Qi Pharma Co., Ltd. romanized | 国药准字H20265780 | 25mg | Category B | XM01AXA267A001010184125 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20256365 | 25mg | Category B | XM01AXA267A001010184221 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010200177 | NHSA |
| Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 25mg | Category B | XM01AXA267A001010200591 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010201503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010201522 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010203307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010204339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010204647 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20266052 | 25mg | Category B | XM01AXA267A001010204929 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010205001 | NHSA |
| Jiangxi Ke Lun Pharma Co., Ltd. romanized | 国药准字H20263509 | 25mg | Category B | XM01AXA267A001010205319 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20263205 | 25mg | Category B | XM01AXA267A001010205815 | NHSA |
| Hainan Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 25mg | Category B | XM01AXA267A001010205849 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20264700 | 25mg | Category B | XM01AXA267A001010205911 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010209568 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20256507 | 25mg | Category B | XM01AXA267A001010280685 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20254798 | 25mg | Category B | XM01AXA267A001010280937 | NHSA |
| Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20255709 | 25mg | Category B | XM01AXA267A001010283830 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010300177 | NHSA |
| Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 25mg | Category B | XM01AXA267A001010300591 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010301503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010301522 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010303307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010304339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010304647 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010305001 | NHSA |
| Jiangxi Ke Lun Pharma Co., Ltd. romanized | 国药准字H20263509 | 25mg | Category B | XM01AXA267A001010305319 | NHSA |
| Hainan Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 25mg | Category B | XM01AXA267A001010305849 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010309568 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20256507 | 25mg | Category B | XM01AXA267A001010380685 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20254798 | 25mg | Category B | XM01AXA267A001010380937 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010400177 | NHSA |
| Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 25mg | Category B | XM01AXA267A001010400591 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010401503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010401522 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010403307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010404339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010404647 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010405001 | NHSA |
| Hainan Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 25mg | Category B | XM01AXA267A001010405849 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010409568 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010500177 | NHSA |
| Jin Hong Pharma Co., Ltd. romanized | 国药准字H20265015 | 25mg | Category B | XM01AXA267A001010500591 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010501503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010501522 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010503307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010504339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010504647 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010505001 | NHSA |
| Hainan Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20110084 | 25mg | Category B | XM01AXA267A001010505849 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010509568 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 25mg | Category B | XM01AXA267A001010600177 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 25mg | Category B | XM01AXA267A001010601503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244320 | 25mg | Category B | XM01AXA267A001010601522 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010603307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010604339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20264636 | 25mg | Category B | XM01AXA267A001010604647 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010605001 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010609568 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010703307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010704339 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010705001 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254383 | See source | Category B | XM01AXA267A001010709568 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010803307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010804339 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010805001 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001010903307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001010904339 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001010905001 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011003307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001011004339 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001011005001 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011103307 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264887 | 25mg | Category B | XM01AXA267A001011104339 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001011105001 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011203307 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20265477 | 25mg | Category B | XM01AXA267A001011205001 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011303307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011403307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011503307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011603307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011703307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011803307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001011903307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012003307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012103307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012203307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012303307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012403307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012503307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012603307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012703307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012803307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001012903307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001013003307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001013103307 | NHSA |
| Changchun Hai Yue Pharma Co., Ltd. romanized | 国药准字H20263178 | 25mg | Category B | XM01AXA267A001013203307 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010104127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010204127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010304127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010404127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010504127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010604127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010704127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010804127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001010904127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20266207 | 25mg | Category B | XM01AXA267A001011004127 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 23 filings and 23 distinct first applicants.
Generic 22 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Name not romanized; Zi Bo Wan Jie Pharmaceutical Co., Ltd. romanized | CYHS2602038 | Generic | 2026/08/18 | Not stated by source | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | CYHS2602106 | Generic | 2026/08/24 | Not stated by source | CDE |
| Shandong Xin Lu Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2503936 | Generic | 2025/11/13 | Not stated by source | CDE |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2503290 | Generic | 2025/09/05 | Not stated by source | CDE |
| Jiangsu Kang Yuan Pharma Co., Ltd. romanized | CYHS2600831 | Generic | 2026/04/10 | Not stated by source | CDE |
| Nanjing Huang Long Bio Technology Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2503798 | Generic | 2025/10/28 | Not stated by source | CDE |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | CYHS2503905 | Generic | 2025/11/08 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized; Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | CYHB2600508 | Supplement | 2026/03/13 | Not stated by source | CDE |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | CYHS2502366 | Generic | 2025/07/04 | Not stated by source | CDE |
| Nanjing Rui Jie Pharmaceuticals Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601615 | Generic | 2026/07/07 | Not stated by source | CDE |
| Zhejiang Shan Yuan Pharmaceutical Co., Ltd. romanized | CYHS2601864 | Generic | 2026/08/03 | Not stated by source | CDE |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CYHS2601490 | Generic | 2026/06/24 | Not stated by source | CDE |
| Shenyang Xin Rui Pharmaceutical Co., Ltd. romanized | CYHS2601227 | Generic | 2026/06/01 | Not stated by source | CDE |
| Shanxi Tong Da Pharma Co., Ltd. romanized | CYHS2600901 | Generic | 2026/04/21 | Not stated by source | CDE |
| Guo Yao Group Chuan Kang Pharmaceutical Co., Ltd. romanized | CYHS2600569 | Generic | 2026/02/27 | Not stated by source | CDE |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | CYHS2600536 | Generic | 2026/02/26 | Not stated by source | CDE |
| Zhong Huan Bio Technology (Fuzhou) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2600367 | Generic | 2026/02/04 | Not stated by source | CDE |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | CYHS2600186 | Generic | 2026/01/15 | Not stated by source | CDE |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | CYHS2600049 | Generic | 2026/01/06 | Not stated by source | CDE |
| TIANJIN LISHENG PHARMACEUTICAL CO., LTD | CYHS2504331 | Generic | 2025/12/19 | Not stated by source | CDE |
| Henan Nuo Mei Pharma Co., Ltd. romanized | CYHS2504029 | Generic | 2025/11/21 | Not stated by source | CDE |
| Chi Feng Wan Ze Pharma Co., Ltd. romanized | CYHS2503774 | Generic | 2025/10/23 | Not stated by source | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | CYHS2503395 | Generic | 2025/09/13 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 13 filings and 13 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Name not romanized; Zi Bo Wan Jie Pharmaceutical Co., Ltd. romanized | CYHS2602038 | Generic | 2026/08/18 | Not stated by source | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | CYHS2602106 | Generic | 2026/08/24 | Not stated by source | CDE |
| Jiangsu Kang Yuan Pharma Co., Ltd. romanized | CYHS2600831 | Generic | 2026/04/10 | Not stated by source | CDE |
| Nanjing Rui Jie Pharmaceuticals Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601615 | Generic | 2026/07/07 | Not stated by source | CDE |
| Zhejiang Shan Yuan Pharmaceutical Co., Ltd. romanized | CYHS2601864 | Generic | 2026/08/03 | Not stated by source | CDE |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CYHS2601490 | Generic | 2026/06/24 | Not stated by source | CDE |
| Shenyang Xin Rui Pharmaceutical Co., Ltd. romanized | CYHS2601227 | Generic | 2026/06/01 | Not stated by source | CDE |
| Shanxi Tong Da Pharma Co., Ltd. romanized | CYHS2600901 | Generic | 2026/04/21 | Not stated by source | CDE |
| Guo Yao Group Chuan Kang Pharmaceutical Co., Ltd. romanized | CYHS2600569 | Generic | 2026/02/27 | Not stated by source | CDE |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | CYHS2600536 | Generic | 2026/02/26 | Not stated by source | CDE |
| Zhong Huan Bio Technology (Fuzhou) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2600367 | Generic | 2026/02/04 | Not stated by source | CDE |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | CYHS2600186 | Generic | 2026/01/15 | Not stated by source | CDE |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | CYHS2600049 | Generic | 2026/01/06 | Not stated by source | CDE |
API registrations
Non-component matches: 23 companies with A status and 8 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 艾拉莫德 · No verified English name | Shandong Lukang Pharmaceutical Co.,Ltd. | Y20260000322 | I | Exact ingredient | 2026/05/26 | CDE |
| 艾拉莫德 · No verified English name | Anhui Bei Ke Pharmaceutical Co., Ltd. romanized | Y20250000960 | I | Exact ingredient | 2026/01/30 | CDE |
| 艾拉莫德 · No verified English name | Suzhou Sheng Da Pharma Co., Ltd. romanized | Y20250001427 | I | Exact ingredient | 2026/01/08 | CDE |
| 艾拉莫德 · No verified English name | Hubei Sai Ao Biopharmaceutical Co., Ltd. romanized | Y20250001405 | I | Exact ingredient | 2025/12/26 | CDE |
| 艾拉莫德 · No verified English name | Wu Xue Hong Yuan Pharma Co., Ltd. romanized | Y20250001272 | I | Exact ingredient | 2025/12/09 | CDE |
| 艾拉莫德 · No verified English name | Zhejiang Dong Ya Pharma Co., Ltd. romanized | Y20250001037 | I | Exact ingredient | 2025/11/05 | CDE |
| 艾拉莫德 · No verified English name | Wei Nan Rui Lian Pharmaceutical Co., Ltd. romanized | Y20250000883 | I | Exact ingredient | 2025/09/09 | CDE |
| 艾拉莫德 · No verified English name | Jiangsu Xian Sheng Biopharmaceuticals Co., Ltd. romanized | Y20250000346 | A | Exact ingredient | 2026/10/31 | CDE |
| 艾拉莫德 · No verified English name | Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20250000295 | A | Exact ingredient | 2026/09/01 | CDE |
| 艾拉莫德 · No verified English name | Liaoning Bei Feng Pharma Co., Ltd. romanized | Y20250000328 | A | Exact ingredient | 2026/10/21 | CDE |
| 艾拉莫德 · No verified English name | Gansu Hao Tian Pharmaceuticals Technology Co., Ltd. romanized | Y20250000183 | A | Exact ingredient | 2026/11/05 | CDE |
| 艾拉莫德 · No verified English name | Hubei Sai Ao Biopharmaceutical Co., Ltd. romanized | Y20240001519 | I | Exact ingredient | 2025/01/27 | CDE |
| 艾拉莫德 · No verified English name | Yi Chang Dong Yang Guang Pharmaceutical Co., Ltd. romanized | Y20250000019 | A | Exact ingredient | 2026/10/16 | CDE |
| 艾拉莫德 · No verified English name | Tianjin Tai Pu Pharmaceutical Co., Ltd. romanized | Y20240001502 | A | Exact ingredient | 2026/05/21 | CDE |
| 艾拉莫德 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20240001460 | A | Exact ingredient | 2026/05/21 | CDE |
| 艾拉莫德 · No verified English name | Jin Hong Pharma Co., Ltd. romanized | Y20240001446 | A | Exact ingredient | 2026/06/23 | CDE |
| 艾拉莫德 · No verified English name | Chi Feng Wan Ze Pharma Co., Ltd. romanized | Y20240001280 | A | Exact ingredient | 2026/05/15 | CDE |
| 艾拉莫德 · No verified English name | Zhejiang Heng Kang Pharma Co., Ltd. romanized | Y20240000734 | A | Exact ingredient | 2026/05/20 | CDE |
| 艾拉莫德 · No verified English name | Sichuan Kelun Pharmaceutical Co., Ltd. | Y20240000983 | A | Exact ingredient | 2026/01/22 | CDE |
| 艾拉莫德 · No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240001010 | A | Exact ingredient | 2026/02/28 | CDE |
| 艾拉莫德 · No verified English name | Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | Y20240000738 | A | Exact ingredient | 2026/01/29 | CDE |
| 艾拉莫德 · No verified English name | Qi Dong Dong Yue Pharma Co., Ltd. romanized | Y20240000615 | A | Exact ingredient | 2026/01/20 | CDE |
| 艾拉莫德 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20240000377 | A | Exact ingredient | 2025/11/26 | CDE |
| 艾拉莫德 · No verified English name | Sichuan Gowell Pharmaceutical Co., Ltd. | Y20240000438 | A | Exact ingredient | 2026/03/04 | CDE |
| 艾拉莫德 · No verified English name | Sichuan Qing Mu Pharmaceutical Co., Ltd. romanized | Y20240000351 | A | Exact ingredient | 2025/07/11 | CDE |
| 艾拉莫德 · No verified English name | Anhui Ai Li De Pharmaceutical Co., Ltd. romanized | Y20240000330 | A | Exact ingredient | 2025/09/04 | CDE |
| 艾拉莫德 · No verified English name | Qian Hui Pharma (Anhui) Co., Ltd. romanized | Y20240000054 | A | Exact ingredient | 2025/07/04 | CDE |
| 艾拉莫德 · No verified English name | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Y20240000045 | A | Exact ingredient | 2025/10/28 | CDE |
| 艾拉莫德 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20230000282 | A | Exact ingredient | 2026/10/23 | CDE |
| 艾拉莫德 · No verified English name | Jiangsu Run An Pharmaceutical Co., Ltd. romanized | Y20190021542 | A | Exact ingredient | 2026/03/18 | CDE |
| 艾拉莫德 · No verified English name | Hainan Xian Sheng Pharma Co., Ltd. romanized | Y20190006390 | A | Exact ingredient | 2026/03/18 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/06No longer listed under review
Jiangsu Yue Xing Pharma Co., Ltd. romanized
CYHS2501616
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/04/30
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/20Marketing application approved
Hefei Hua Wei Pharma Co., Ltd. romanized
CYHS2503158 · 国药准字H20266385
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 101 ↗ -
2026/10/20Marketing application approved
Name not romanized
CYHS2502395 · 国药准字H20266383
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 79 ↗ -
2026/10/20Marketing application approved
Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized
CYHS2501715 · 国药准字H20266320
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 63 ↗ -
2026/08/24Accepted
Shandong Lukang Pharmaceutical Co.,Ltd.
CYHS2602106
Fact date: 2026/08/24 · Site observation date: 2026/10/21
View source ↗ -
2026/08/18Accepted
Name not romanized; Zi Bo Wan Jie Pharmaceutical Co., Ltd. romanized
CYHS2602038
Fact date: 2026/08/18 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Iguratimod Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy